• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Monopar Therapeutics Inc. - Common Stock (NQ:MNPR)

    66.01 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 8
    Open 66.01
    Bid (Size) 26.41 (200)
    Ask (Size) 99.90 (100)
    Prev. Close 66.01
    Today's Range 66.01 - 66.01
    52wk Range 22.50 - 105.00
    Shares Outstanding 14,157,941
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
    As the final bells ring on Wall Street for 2025, the biotechnology sector is celebrating a dramatic reversal of fortune. After years of navigating high interest rates and regulatory uncertainty, the... 
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    This Home Depot Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday ↗
     
    Via Benzinga

    Performance

    YTD
    N/A
    N/A
    1 Month
    -17.9%
    -17.9%
    3 Month
    -33.7%
    -33.7%
    6 Month
    +77.4%
    +77.4%
    1 Year
    +179.7%
    +179.7%

    More News

    Read More
    News headline image
    Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
    Via Benzinga
    News headline image
    CrowdStrike To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday ↗
    Via Benzinga
    News headline image
    Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Monopar Announces Journal of Hepatology Publishes Physicians’ Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Why Monopar Therapeutics, A Top 1% Biotech Stock, Just Surged Into A Breakout ↗
    Via Investor's Business Daily
    News headline image
    Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Monopar Announces Abstract Accepted with Distinction for Oral and Poster Presentations at the Upcoming American Neurological Association 2025 Annual Meeting
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Monopar Therapeutics Reports Second Quarter 2025 Financial Results and Recent Developments
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    This Hilton Worldwide Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
    Via Benzinga
    News headline image
    Monopar and EDNOC Announce Expanded Access Program for MNPR-101-Zr and MNPR-101-Lu in Advanced Cancers
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Monopar Therapeutics Announces Inclusion in the Russell 3000® and Russell 2000® Indexes
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Monopar Announces ALXN1840 Data Selected for Late-Breaker Presentation at EASL Congress 2025
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
    From Monopar Therapeutics Inc.
    Via GlobeNewswire
    News headline image
    Monopar to Present at the 36th Annual Piper Sandler Healthcare Conference
    From Monopar Therapeutics Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Monopar Therapeutics Inc. - Common Stock publicly traded?
    Yes, Monopar Therapeutics Inc. - Common Stock is publicly traded.
    What exchange does Monopar Therapeutics Inc. - Common Stock trade on?
    Monopar Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Monopar Therapeutics Inc. - Common Stock?
    The ticker symbol for Monopar Therapeutics Inc. - Common Stock is MNPR on the Nasdaq Stock Market
    What is the current price of Monopar Therapeutics Inc. - Common Stock?
    The current price of Monopar Therapeutics Inc. - Common Stock is 66.01
    When was Monopar Therapeutics Inc. - Common Stock last traded?
    The last trade of Monopar Therapeutics Inc. - Common Stock was at 01/02/26 04:00 PM ET
    What is the market capitalization of Monopar Therapeutics Inc. - Common Stock?
    The market capitalization of Monopar Therapeutics Inc. - Common Stock is 934.57M
    How many shares of Monopar Therapeutics Inc. - Common Stock are outstanding?
    Monopar Therapeutics Inc. - Common Stock has 935M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.